Yasmin is a drug owned by Bayer Healthcare Pharmaceuticals Inc. It is protected by 3 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 31, 2020. Details of Yasmin's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6787531 | Pharmaceutical composition for use as a contraceptive |
Aug, 2020
(4 years ago) |
Expired
|
| US6933395 | PROCESSING FOR PRODUCING OF DROSPIRENONE (6β, 7β, 15β, 16β-DIMETHYLENE-3-OXO-17α-PREGN-4-EN-21, 17-CARBOLACTONE, DRSP) AS WELL AS 7α-(3-HYDOXY-1-PROPLY)-6β, 7β; 15β, 16β-DIMETHYLENE-5β-ANDROSTANE-3β, 5,17β-TRIOL(ZK 92836) AND 6β, 7β; 15β, 16β-DIMETHYLENE-5β-HYDROXY |
Aug, 2017
(7 years ago) |
Expired
|
| US5569652 | Dihydrospirorenone as an antiandrogen |
Oct, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Yasmin is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Yasmin's family patents as well as insights into ongoing legal events on those patents.
Yasmin's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Yasmin's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 31, 2020 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Yasmin Generic API suppliers:
Drospirenone; Ethinyl Estradiol is the generic name for the brand Yasmin. 14 different companies have already filed for the generic of Yasmin, with Xiromed having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Yasmin's generic
How can I launch a generic of Yasmin before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Yasmin's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Yasmin's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Yasmin -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 3 mg/0.03 mg | 07 Jan, 2005 | 1 | 09 May, 2008 | 31 Aug, 2020 | Extinguished |
Alternative Brands for Yasmin
Yasmin which is used for contraception., has several other brand drugs in the same treatment category and using the same active ingredient (Drospirenone; Ethinyl Estradiol). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | Treatment Area | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apil |
| |||||||||||
| Bayer Hlthcare |
| |||||||||||
| Evofem Inc |
| |||||||||||
| Organon |
| |||||||||||
| Teva Branded Pharm |
| |||||||||||
| Wyeth Pharms Inc |
| |||||||||||
Apart from brand drugs containing the same ingredient, some generics have also been filed for Drospirenone; Ethinyl Estradiol, Yasmin's active ingredient. Check the complete list of approved generic manufacturers for Yasmin
About Yasmin
Yasmin is a drug owned by Bayer Healthcare Pharmaceuticals Inc. It is used for contraception. Yasmin uses Drospirenone; Ethinyl Estradiol as an active ingredient. Yasmin was launched by Bayer Hlthcare in 2001.
Approval Date:
Yasmin was approved by FDA for market use on 11 May, 2001.
Active Ingredient:
Yasmin uses Drospirenone; Ethinyl Estradiol as the active ingredient. Check out other Drugs and Companies using Drospirenone; Ethinyl Estradiol ingredient
Treatment:
Yasmin is used for contraception.
Dosage:
Yasmin is available in tablet form for oral-28 use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 3MG;0.03MG | TABLET | Prescription | ORAL-28 |